Eloxx Pharmaceuticals, Inc. (ELOX): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-40, first reflected in a filing dated 2023-03-31; 1-for-11, first reflected in a filing dated 2026-06-01. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

4.79M

As of 2025-12-31

4.04M

As of 2026-06-30

2011-06-30 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	4.79M	+35.5%	2026-03-17, Balance as of period end
2024-12-31	3.53M	+12.4%	2026-03-17, Balance as of period end
2023-12-31	3.14M	n/c	2026-03-17, Balance as of period end
2022-12-31	2.17M	0.0%	2023-03-31, Balance as of period end
2021-12-31	2.17M	n/c	2023-03-31, Balance as of period end
2020-12-31	40.16M	+0.3%	2022-03-30, Balance as of period end
2019-12-31	40.03M	+11.6%	2021-03-12, Balance as of period end
2018-12-31	35.86M	+30.3%	2020-03-06, Balance as of period end
2017-12-31	27.53M	n/a	2019-03-14, Balance as of period end
2017-06-30	29.20M	n/a	2017-10-13, Balance as of period end
2016-12-31	4.21M	n/c	2018-03-16, Balance as of period end
2016-06-30	20.50M	+9.3%	2017-10-13, Balance as of period end
2015-06-30	18.75M	+35.4%	2016-10-13, Balance as of period end
2014-06-30	13.85M	+509.4%	2015-10-09, Balance as of period end
2013-06-30	2.27M	-97.6%	2014-09-29, Balance as of period end
2012-06-30	94.11M	+21.0%	2013-09-11, Balance as of period end
2011-06-30	77.77M	n/a	2012-10-26, Balance as of period end